Wambolt & Associates’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,853
Closed -$202K 242
2023
Q2
$202K Buy
+1,853
New +$198K 0.07% 239
2023
Q1
Sell
-2,499
Closed -$274K 260
2022
Q4
$274K Sell
2,499
-110
-4% -$11.4K 0.11% 196
2022
Q3
$252K Sell
2,609
-40
-2% -$4.26K 0.11% 203
2022
Q2
$288K Sell
2,649
-63
-2% -$7.16K 0.12% 191
2022
Q1
$322K Buy
2,712
+43
+2% +$5.33K 0.12% 190
2021
Q4
$376K Sell
2,669
-2
-0.1% -$256 0.14% 172
2021
Q3
$313K Buy
2,671
+52
+2% +$6.39K 0.13% 184
2021
Q2
$307K Buy
2,619
+750
+40% +$87.4K 0.13% 187
2021
Q1
$222K Buy
1,869
+20
+1% +$2.37K 0.12% 199
2020
Q4
$202K Sell
1,849
-847
-31% -$92.1K 0.12% 200
2020
Q3
$293K Buy
+2,696
New +$274K 0.22% 152

Other funds holding ABT

Wambolt & Associates's ABT Position: Q3 2023 in Review

Wambolt & Associates sold out of Abbott (ABT) in Q3 2023, closing a stake of 1,853 shares — an estimated $202K sold.

Wambolt & Associates first reported a position in ABT in Q3 2020 and held it in 11 quarters. The position peaked at $376K in Q4 2021. 2,682 funds tracked by Wall St. Rank hold ABT as of Q3 2023.

  • Wambolt & Associates reported no remaining Abbott position as of Q3 2023 after selling out during the quarter.
  • Wambolt & Associates sold 1,853 Abbott shares in Q3 2023, an estimated $202K.
  • Wambolt & Associates first reported a position in Abbott in Q3 2020 and held it in 11 quarters.
  • Wambolt & Associates's Abbott position peaked at $376K in Q4 2021.
  • 2,682 funds tracked by Wall St. Rank held Abbott as of Q3 2023.

Based on Wambolt & Associates's 13F filing for Q3 2023, filed 7 Nov 2023.